James R. Empfield

1.0k total citations
17 papers, 369 citations indexed

About

James R. Empfield is a scholar working on Organic Chemistry, Molecular Biology and Urology. According to data from OpenAlex, James R. Empfield has authored 17 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Molecular Biology and 3 papers in Urology. Recurrent topics in James R. Empfield's work include Phytochemistry and Bioactive Compounds (3 papers), Urinary Bladder and Prostate Research (3 papers) and Cancer Treatment and Pharmacology (2 papers). James R. Empfield is often cited by papers focused on Phytochemistry and Bioactive Compounds (3 papers), Urinary Bladder and Prostate Research (3 papers) and Cancer Treatment and Pharmacology (2 papers). James R. Empfield collaborates with scholars based in United States, France and Germany. James R. Empfield's co-authors include Amos B. Smith, Henry A. Vaccaro, Don E. Pivonka, Diane A. Trainor, Mineo Fukui, Ralph A. Rivero, Karen Russell, Khanh Bui, Yun W. Alelyunas and Dennis J. McCarthy and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

James R. Empfield

16 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James R. Empfield United States 11 163 139 76 38 32 17 369
Irene Drizin United States 11 192 1.2× 132 0.9× 20 0.3× 43 1.1× 13 0.4× 13 363
Hilmi Burak Kandilci Türkiye 12 402 2.5× 176 1.3× 6 0.1× 63 1.7× 49 1.5× 24 676
Shou Wu Miao United States 8 248 1.5× 138 1.0× 34 0.4× 41 1.1× 9 0.3× 8 364
Hideyuki Adachi Japan 11 212 1.3× 266 1.9× 3 0.0× 73 1.9× 67 2.1× 25 560
Dina Baier Austria 14 93 0.6× 117 0.8× 9 0.1× 9 0.2× 4 0.1× 28 358
Tom R. Jones Canada 9 107 0.7× 200 1.4× 6 0.1× 38 1.0× 40 1.3× 15 337
Karl Schönafinger Germany 10 304 1.9× 176 1.3× 3 0.0× 18 0.5× 65 2.0× 17 570
Hartmut Strobel Germany 8 75 0.5× 129 0.9× 6 0.1× 16 0.4× 88 2.8× 14 367
Charles W. Lugar United States 11 221 1.4× 175 1.3× 3 0.0× 38 1.0× 3 0.1× 14 523
Y Shiokawa Japan 9 185 1.1× 105 0.8× 3 0.0× 16 0.4× 20 0.6× 33 333

Countries citing papers authored by James R. Empfield

Since Specialization
Citations

This map shows the geographic impact of James R. Empfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Empfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Empfield more than expected).

Fields of papers citing papers by James R. Empfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. Empfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Empfield. The network helps show where James R. Empfield may publish in the future.

Co-authorship network of co-authors of James R. Empfield

This figure shows the co-authorship network connecting the top 25 collaborators of James R. Empfield. A scholar is included among the top collaborators of James R. Empfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Empfield. James R. Empfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sun, Shaoyi, Qi Jia, Sophia Lin, et al.. (2021). Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5. Bioorganic & Medicinal Chemistry Letters. 45. 128133–128133. 2 indexed citations
2.
Empfield, James R. & Michael P. Clark. (2014). Reducing Drug Attrition. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 3 indexed citations
3.
Alelyunas, Yun W., et al.. (2010). Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & Medicinal Chemistry Letters. 20(24). 7312–7316. 46 indexed citations
4.
Pivonka, Don E. & James R. Empfield. (2004). Real-Time in situ Raman Analysis of Microwave-Assisted Organic Reactions. Applied Spectroscopy. 58(1). 41–46. 37 indexed citations
5.
Brown, Dean G., Rebecca A. Urbanek, Gary B. Steelman, et al.. (2003). Synthesis of 7-chloro-2,3-dihydro-2-[1-(pyridinyl)alkyl]-pyridazino[4,5-b]quinoline-1,4,10(5H)-triones as NMDA glycine-site antagonists. Bioorganic & Medicinal Chemistry Letters. 13(20). 3553–3556. 14 indexed citations
6.
Smith, Amos B. & James R. Empfield. (1999). Synthetic Strategies Towards the Total Synthesis of Phyllanthocin and Breynolide. Application of Stereochemically Linear and Convergent Strategies.. Chemical and Pharmaceutical Bulletin. 47(12). 1671–1678. 17 indexed citations
7.
Empfield, James R., et al.. (1997). 4-Sulfonamidoanilide tertiary carbinols: A novel series of potassium channel openers. Bioorganic & Medicinal Chemistry Letters. 7(7). 775–778. 8 indexed citations
8.
Russell, Keith C., et al.. (1995). Calcium-Dependent K-Channels in Guinea Pig and Human Urinary Bladder. Biochemical and Biophysical Research Communications. 213(2). 404–409. 28 indexed citations
9.
Kau, Sen T., Keith C. Russell, James R. Empfield, et al.. (1995). Zeneca ZD6169 and Its Analogs from a Novel Series of Anilide Tertiary Carbinols: In vitro K<sub>ATP</sub> Channel Opening Activity in Bladder Detrusor. Pharmacology. 51(1). 33–42. 22 indexed citations
10.
Russell, Karen, et al.. (1995). ZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 884–890. 72 indexed citations
11.
Smith, Amos B., et al.. (1992). Total synthesis of (.+-.)-breynolide, an aglycon derivative of the orally active hypocholesterolemic agent breynin A. Journal of the American Chemical Society. 114(24). 9419–9434. 24 indexed citations
12.
13.
Smith, Amos B., Mineo Fukui, Henry A. Vaccaro, & James R. Empfield. (1991). Phyllanthoside-phyllanthostatin synthetic studies. 7. Total synthesis of (+)-phyllanthocin and (+)-phyllanthocindiol. Journal of the American Chemical Society. 113(6). 2071–2092. 40 indexed citations
14.
Smith, Amos B., James R. Empfield, Ralph A. Rivero, & Henry A. Vaccaro. (1991). Total synthesis of (.+-.)-breynolide: an aglycon derivative of a potent, orally active hypocholesterolemic agent. Journal of the American Chemical Society. 113(10). 4037–4038. 13 indexed citations
15.
Chen, Bang‐Chi, Michael C. Weismiller, Franklin A. Davis, et al.. (1991). Enantioselective synthesis of (+)-kjellmanianone. Tetrahedron. 47(2). 173–182. 33 indexed citations
16.
Smith, Amos B., James R. Empfield, & Henry A. Vaccaro. (1989). Phyllanthoside-Phyllanthostatin synthetic studies. 6. An augmented spiroketalization tactic for the total synthesis of phyllanthocin. Tetrahedron Letters. 30(52). 7325–7328. 6 indexed citations
17.
Heine, Harold W., et al.. (1986). Reactions of o-quinone monoimides with sulfoxides, diazoalkanes, and triphenylphosphine. The Journal of Organic Chemistry. 51(6). 829–833. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026